Determining the presence of atypical antibodies to red cell antigens in patient plasma or serum.
Investigation of immune-mediated hemolytic anemia.
Identifying antibody(ies) in prenatal patients to assist in determining the risk for Hemolytic Disease of the Fetus and Newborn (HDFN).